Stock 603566 PULIKE BIOLOGICAL ENGINEERING, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Pulike Biological Engineering, Inc.

Equities

603566

CNE1000025N0

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-05-09 pm EDT 		5-day change 1st Jan Change
19.92 CNY +3.75% Intraday chart for Pulike Biological Engineering, Inc. +14.29% -12.05%
Apr. 25 Pulike Biological Engineering, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 25 Pulike Biological Engineering, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

Pulike Biological Engineering. Inc is principally engaged in the research, development, production and distribution of veterinary biological products and chemical medicines. The Company's veterinary biological products include vaccine and antibody, applied in the prevention and controlling of infection to epidemic disease for poultry and livestock. Its veterinary chemical medicines are mainly used in the treatment of epidemic diseases of poultry and livestock.

Number of employees: 1,718

Sales per Business

CNY in Million2022Weight2023Weight Delta
Pig Vaccines
34.7 %
462 37.6 % 434 34.7 % -5.92%
Poultry Vaccines and Antibodies
33.2 %
377 30.7 % 416 33.2 % +10.20%
Chemical
30.2 %
344 28.0 % 379 30.2 % +10.14%
Other Business
0.8 %
13 1.1 % 10 0.8 % -23.22%
Functional Health Products
0.6 %
- - 8 0.6 % -
Technology License or Transfer Income
0.4 %
32 2.6 % 5 0.4 % -85.53%
Vaccines for Ruminants
0.1 %
- - 1 0.1 % -

Sales per region

CNY in Million2022Weight2023Weight Delta
China
98.7 %
1,196 98.4 % 1,227 98.7 % +2.58%
Overseas
1.3 %
19 1.6 % 16 1.3 % -16.24%

Managers

Managers TitleAgeSince
Fei Hu CEO
 Chief Executive Officer 51 -
Lian Feng Pei DFI
 Director of Finance/CFO 51 11-03-22
Rui Zhao BRD
 Director/Board Member 40 16-05-03
De Chao Qin BRD
 Director/Board Member 53 -
Yong Jun Song BRD
 Director/Board Member 56 -
Xiao Long Tian IRC
 Investor Relations Contact 39 13-08-31
Ke Gong Tian PRN
 Corporate Officer/Principal 60 -

Members of the board

Members of the board TitleAgeSince
Yong Chang Cao BRD
 Director/Board Member 59 23-04-10
Fei Hu CEO
 Chief Executive Officer 51 -
Xu Ke Zhang CHM
 Chairman 61 11-03-22
Yong Jun Song BRD
 Director/Board Member 56 -
De Chao Qin BRD
 Director/Board Member 53 -
Ke Gong Tian PRN
 Corporate Officer/Principal 60 -
Chu Duan Wang BRD
 Director/Board Member 56 23-04-10
Rui Zhao BRD
 Director/Board Member 40 16-05-03
Li Peng Zhou CHM
 Chairman 47 23-04-10
Xiao Long Tian IRC
 Investor Relations Contact 39 13-08-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 352,916,573 181,555,271 ( 51.44 %) 6,854,300 ( 1.942 %) 51.44 %

Shareholders

NameEquities%Valuation
Xu Ke Zhang
30.64 %
107,619,672 30.64 % 260 M ¥
Jin Zhong Sun
4.785 %
16,807,218 4.785 % 41 M ¥
CITIC LIMITED
2.733 %
9,599,915 2.733 % 23 M ¥
China State-Owned Assets Supervision & Admn Commission
1.992 %
6,997,900 1.992 % 17 M ¥
Zhong Ou Asset Management Co., Ltd
1.559 %
5,475,766 1.559 % 13 M ¥
Origin Asset Management Co. Ltd.
1.534 %
5,388,383 1.534 % 13 M ¥
Guotai Asset Management Co., Ltd.
1.281 %
4,500,000 1.281 % 11 M ¥
Fei Hu
1.192 %
4,186,720 1.192 % 10 M ¥
Harvest Fund Management Co., Ltd.
1.156 %
4,058,782 1.156 % 10 M ¥
Hai Ping Li
1.150 %
4,040,326 1.150 % 10 M ¥

Company contact information

Pulike Biological Engineering, Inc.

15, Zhenghe Road Luolong District

471000, Luoyang

+

http://www.pulike.com.cn
address Pulike Biological Engineering, Inc.(603566)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Veterinary Drugs

Sales per Business

Sales per region

Ratings for Pulike Biological Engineering, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
19.92 CNY
Average target price
20.24 CNY
Spread / Average Target
+1.58%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Veterinary Drugs

1st Jan change Capi.
PULIKE BIOLOGICAL ENGINEERING, INC. Stock Pulike Biological Engineering, Inc.
-12.05% 950M
ZOETIS INC. Stock Zoetis Inc.
-14.35% 77.13B
ELANCO ANIMAL HEALTH INCORPORATED Stock Elanco Animal Health Incorporated
+14.09% 8.4B
BLUESTAR ADISSEO COMPANY Stock Bluestar Adisseo Company
+27.62% 3.79B
VIRBAC Stock Virbac
-0.70% 3.22B
VIMIAN GROUP AB Stock Vimian Group AB
+14.70% 1.64B
JINYU BIO-TECHNOLOGY CO., LTD. Stock Jinyu Bio-technology Co., Ltd.
-10.12% 1.5B
CHINA ANIMAL HUSBANDRY INDUSTRY CO., LTD. Stock China Animal Husbandry Industry Co., Ltd.
-22.60% 1.3B
VETOQUINOL SA Stock Vetoquinol SA
-4.20% 1.25B
WUHAN KEQIAN BIOLOGY CO.,LTD Stock Wuhan Keqian Biology Co.,Ltd
-10.26% 1.18B
Veterinary Drugs
  1. Stock Market
  2. Equities
  3. 603566 Stock
  4. Company Pulike Biological Engineering, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW